Table of Contents
The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.
This report provides:
An overview of the global market for drugs and therapeutics used to treat systemic lupus erythematosus (SLE)
Analyses of global market trends, with data from 2013 and projections of CAGRs through 2018.
Analyses of factors influencing market demand such as the industry's structure, governmental regulations, and developing technologies
Details concerning the developmental product pipeline for therapeutics uesd to treat SLE
Profiles of leading companies in the industry.
STUDY GOALS AND OBJECTIVES
BCC Research’s goal in conducting this study was to determine the current status of systemic lupus erythematosus (SLE) disease treatments and assess the growth potential of this area over a five-year period, from 2013 to 2018. Our key objective was to present a comprehensive analysis of the current pipeline of therapeutics, analyze the market and forecast for SLE therapeutics along with outlining the key factors that will influence this therapeutic area in the next few years.
REASONS FOR DOING THIS STUDY
SLE is a devastating and chronic autoimmune disorder affecting almost all the organs, with only one approved marketed drug — making this a significant area of unmet medical need. But there are now numerous companies developing novel treatments. This report will review the programs in development and quantify the market opportunities in SLE drugs.
SCOPE OF REPORT
The scope of this report focuses on the pharmaceutical segment. We have compiled a study of the market, as well as current and emerging modes of treatment. We present the market segment’s economic environment, market factors and potential, and forecasts for 2013 to 2018. This study will be of interest to the drug industry, patients and the medical community. It will also be of interest to suppliers of products and services to this market area.
The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics sector, as well as the medical practitioners who treat patients in these areas.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteopenia and Osteoporosis in13 Major Markets Osteopenia and osteoporosis (“porous bone”) are both terms which help to define ...
Note*: This report requires 5 business days to complete. DelveInsight’s Juvenile idiopathic arthritis (JIA) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...
DelveInsight’s Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Osteoporosis for the seven major markets ...